UPDATE: Mizhuo Initiates Anthem With Neutral, $262 Target Notes Despite Near-Term Managed Medicare Concerns, Long-Term Growth Could Be Attractive If Co. Is Able To Regain Its Lost Commercial Market Share Due To Uncompetitive Pharmacy Costs